Speaker illustration

Miss Asma Al Bulushi

Hamad Medical Corporation, Doha (Qatar)

Cardiovascular risk assessment and modifying cardiotoxicity in breast cancer patients receiving Anthracyclines and Anti-HER2 Therapy

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Poster session (1)

Thumbnail

ESC 365 is supported by